adenocarcinoma
Showing NaN - NaN of 10
NSCLC, NSCLC, Adenocarcinoma Trial in Worldwide (MM-121, Docetaxel)
Terminated
- Non-Small Cell Lung Cancer
- +3 more
-
Tucson, Arizona
- +34 more
Oct 11, 2021
Pancreatic Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Adenocarcinoma Trial in Chicago (Oxaliplatin, Docetaxel,
Recruiting
- Pancreatic Adenocarcinoma
- +2 more
- Oxaliplatin
- +4 more
-
Chicago, IllinoisThe University of Chicago
Jun 7, 2021
Adenocarcinoma Trial in Chicago (Trastuzumab, ABT-806, Bemarituzumab)
Gastric Cancer, Adenocarcinoma Trial in Worldwide (biological, drug, other)
Completed
- Gastric Cancer
- Adenocarcinoma
- ramucirumab
- +2 more
-
Bakersfield, California
- +160 more
Sep 10, 2019
Pancreatic Cancer, Adenocarcinoma, Pancreatic Tumors Trial in San Francisco, Chicago, Madison (FOLFIRINOX, IPI-926)
Completed
- Pancreatic Cancer
- +2 more
- FOLFIRINOX, IPI-926
-
San Francisco, California
- +2 more
Aug 7, 2017
Barrett Syndrome, Barrett's Syndrome, Barrett's Esophagus Trial in France, United Kingdom, United States (Standard endoscopic
Completed
- Barrett Syndrome
- +4 more
- Standard endoscopic evaluation
- pCLE guided evaluation
-
Jacksonville, Florida
- +5 more
Mar 22, 2016
Pancreatic Cancer, Adenocarcinoma Trial in United States (ARQ 501 in combination with gemcitabine)
Completed
- Pancreatic Cancer
- Adenocarcinoma
- ARQ 501 in combination with gemcitabine
-
Mobile, Alabama
- +14 more
Apr 28, 2009
Esophageal Tumors, Stomach Tumors, Adenocarcinoma Trial in United States (tezacitabine, 5-fluorouracil)
Completed
- Esophageal Neoplasms
- +2 more
-
Birmingham, Alabama
- +28 more
Jul 10, 2006